Armeniacae semen is the seed of Prunus armeniaca L. var. ansu MAXIM, which has been classified into Rosaceae. Armeniacae semen is known to have many therapeutic effects such as relieving fever, stopping cough, quenching thirst, and so on. In traditional oriental medicine, Armeniacae semen has been used for the treatment of asthma, bronchitis, emphysema, constipation, nausea, leprosy, and leucoderma.
Pain is first response to injury or infection. Injury and infection activates the immune system to produce an inflammatory responses. 6) Lipopolysaccharide (LPS) initiates a number of major cellular responses that play vital roles in the pathogenesis of inflammatory responses. LPS stimulates the production of inflammatory mediators such as nitric oxide (NO), tumor necrosis factor-a (TNF-a), interleukins, prostaglandin E 2 (PGE 2 ), and leukotrienes. 7, 8) Moreover, LPS enhances the pain response to various somatic stimuli. 9, 10) PGE 2 is a key inflammatory mediator and an increased level of PGE 2 mediates the cardinal features of inflammation such as pain, edema, and fever. 11, 12) PGE 2 is converted from arachidonic acid by cyclooxygenase (COX). There are two isoforms of COX: COX-1 and COX-2. While COX-1 is a constitutively expressed form in normal physiologic functions, COX-2 is expressed only in response to such inflammatory signals such as cytokines and bacterial endotoxin, LPS. COX-2 produces large amount of PGE 2 that induces inflammation. 13, 14) NO is synthesized from L-arginine by nitric oxide synthase (NOS). NO plays an important role in the regulation of many physiological processes. 15) There are three distinct isoforms of NOS: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). Of these, iNOS is an important enzyme involved in the regulation of inflammation. 16) It was reported that LPS upregulates iNOS expression in macrophages 17) and microglial cells. 18) In the present study, the effect of Armeniacae semen extract on the LPS-stimulated expression of COX-1, COX-2, and iNOS in mouse BV2 microglial cells was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, reverse transcription-polymerase chain reaction (RT-PCR), Western blot, PGE 2 immunoassay, and NO detection.
MATERIALS AND METHODS
Cell Culture Mouse BV2 microglial cells were cultured in Dulbecco's modified Eagle's Medium (DMEM; Gibco BRL, Grand Island, NY, U.S.A.) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco BRL) at 37°C in 5% CO 2 -95% O 2 in a humidified cell incubator. The cells were plated onto culture dishes at a density of 2ϫ10 4 cells/cm 2 24 h prior to drug treatments. Preparation of Armeniacae semen Armeniacae semen used in this experiment was obtained from the Kyungdong market (Seoul, Korea). After immersing in 0.1% citric acid for 1 min, Armeniacae semen was rinsed and dried in room temperature for 24 h. Then, it was pulverized by crusher (Hanil, Seoul, Korea) and the fine powder was sifted from the course particles by a mesh screen with a pore diameter of 2 mm. In order to obtain the aqueous extract of Armeniacae semen, the fine powder was subsequently heat-extracted by distilled water, pressure-filtered, and concentrated with a rotary evaporator (Eyela, Tokyo, Japan). The resulting 34.48 g powder (yield of 6.88%) was obtained from 500 g of Armeniacae semen through lyophilization by a drying machine (Ilsin, Kyungkido, Korea) for 24 h. MTT Cytotoxicity Assay Mouse BV2 microglial cells were grown in a final volume of 100 ml culture medium per well in a 96-well plates. In order to determine the cytotoxicity of Armeniacae semen, the cells were treated with Armeniacae semen extract at concentrations of 10 Ϫ3 mg/ml, 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 10 mg/ml for 24 h. Cultures of the cells of the control group were left untreated. After adding 10 ml of the MTT labeling reagent containing 5 mg/ml 3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyl tetrazolium bromide in phosphate-buffered saline to each well, the plates were incubated for 4 h. Solubilization solution 100 ml containing 10% sodium dodecyl sulfate in 0.01 M hydrochloric acid was added to each well, and the cells were incubated for another 12 h. RNA Isolation and RT-PCR To identify the expression of COX-1, COX-2, and iNOS mRNA, RT-PCR was performed. The total RNA was isolated from BV2 cells using RNAzol TM B (TEL-TEST, Friendswood, TX, U.S.A.). Two micrograms of RNA and 2 ml of random hexamers (Promega, Madison, WI, U.S.A.) were added together, and the mixture was heated at 65°C for 10 min. One microliter of AMV reverse transcriptase (Promega), 5 ml of 10 mM dNTP (Promega), 1 ml of RNasin (Promega), and 5 ml of 10ϫAMV RT buffer (Promega) were then added to the mixture, and the final volume was brought up to 50 ml volume with diethylpyrocarbonate (DEPC)-treated water. The reaction mixture was then incubated at 42°C for 1 h.
PCR amplification was performed in a reaction volume of 40 ml containing 1 ml of the appropriate cDNA, 1 ml of each set of primers at a concentration of 10 pM, 4 ml of 10ϫRT buffer, 1 ml of 2.5 mM dNTP, and 2 units of Taq DNA polymerase (Takara, Shiga, Japan). For mouse COX-1, the primer sequences were 5Ј-AGTGCGGTCCAACCTTATCC-3Ј (a 20-mer sense oligonucleotide) and 5Ј-CCGCAGGTGAT-ACTGTCGTT-3Ј (a 20-mer anti-sense oligonucleotide). For mouse COX-2, the primer sequences were 5Ј-CCAGATGC-TATCTTTGGGGAGAC-3Ј (a 23-mer sense oligonucleotide) and 5Ј-CTTGCATTGATGGTGGCTG-3Ј (a 19-mer antisense oligonucleotide). For mouse iNOS, the primer sequences were 5Ј-ATGAGGTACTCAGCGTGCTCCAC-3Ј (a 23-mer sense oligonucleotide) and 5Ј-CCACAATAGTA-CAATACTACTTGG-3Ј (a 24-mer anti-sense oligonucleotide). For cyclophilin, the internal control used in the study, the primer sequences were 5Ј-ACCCCACCGTGTTCTT-CGAC-3Ј (a 20-mer sense oligonucleotide) and 5Ј-CATTTG-CCATGGACAAGATG-3Ј (a 20-mer anti-sense oligonucleotide). The expected size of the PCR product was 381 bp for COX-1, 249 bp for COX-2, 395 bp for iNOS, and 299 bp for cyclophilin.
For COX-1 and iNOS, the PCR procedures were carried out using a GeneAmp 9600 PCR system (Perkin Elmer, Norwalk, CT, U.S.A.) under the following conditions: initial denaturation at 94°C for 5 min, followed by 35 amplification cycles, each consisting of denaturation at 94°C for 45 s, annealing at 60°C for 45 s, and extension at 72°C for 60 s, with an additional extension step at the end of the procedure at 72°C for 10 min. For COX-2, the PCR procedures was under the following conditions: initial denaturation at 94°C for 5 min, followed by 30 amplification cycles, each consisting of denaturation at 94°C for 30 s, annealing at 30°C for 30 s, and extension at 72°C for 60 s, with an additional extension step at the end of the procedure at 72°C for 10 min. For cyclophilin, the PCR procedure was under the following conditions: initial denaturation at 94°C for 5 min, followed by 25 amplification cycles, each consisting of denaturation at 94°C for 30 s, annealing at 55°C, and extension at 72°C for 45 s, with an additional extension step at the end of the procedure at 72°C for 10 min. The final amount of RT-PCR product for each of the mRNA species was calculated densitometrically using Molecular Analyst TM version 1.4.1 (Bio-Rad, Hercules, CA, U.S.A.).
Western Blot Analysis Mouse BV2 microglial cells were lysed in a ice-cold whole cell lysate buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM magnesium chloride hexahydrate, 1 mM ethyleneglycol-bis-(b-aminoethyl ether)-N,NЈ-tetraacetic acid (EGTA), 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mM sodium ortho vanadate, and 100 mM sodium floride, and the mixture was incubated 30 min at 4°C. Cell debris was removed by microcentrifugation, followed by quick freezing of the supernatant. The protein concentration was measured using a BioRad colorimetric protein assay kit (Bio-Rad, Hercules, CA, U.S.A.). Protein of 30 mg was separated on SDS-polyacrylamide gels and transferred onto a nitrocellulose membrane (Schleicher & Schuell GmbH, Dassel, Germany). Goat COX-1 antibody, goat COX-2 antibody (1 : 2000; Santa Cruz Biotech, CA, U.S.A.), and rabbit iNOS antibody (1 : 500; Santa Cruz Biotech) were used as a primary antibody. Horseradish peroxidase-conjugated anti-goat antibody (1 : 2000; Santa Cruz Biotech) was used to probe for COX-1 and COX-2, and anti-rabbit antibody (1 : 2000; Santa Cruz Biotech) for iNOS was used as a secondary antibody. Band detection was performed using the enhanced chemiluminescence (ECL) detection system (Amersham Pharmacia Biothech GmbH, Freiburg, Germany).
Measurement of Prostaglandin E 2 Synthesis Assessment of PGE 2 synthesis was performed using a commercially available PGE 2 competitive enzyme immunoassay kit (Amersham Pharmacia Biotech. Inc., Piscataway, NJ, U.S.A.). Supernatant 100 ml from the culture medium and the standards were put into different wells on the goat anti-mouse IgGcoated microtiter plate provided in the kit. Mouse anti-PGE 2 antibody and peroxidase-conjugated PGE 2 were added to each well, and the plate was incubated at room temperature with shaking for 1 h. The wells were drained and washed, and 3,3Ј,5,5Ј-tetramethylbenzidine/hydrogen peroxide solution was then added. The plate was incubated at room temperature with shaking, and the reaction was stopped after 30 min through the addition of H 2 SO 4 . The absorbance of the content of each well was then measured at a wavelength of 450 nm.
Determination of Nitric Oxide Synthesis In order to determine the effect of Armeniacae semen extract on NO synthesis, the amount of nitrite in the supernatant was measured, based on the Griess reaction, as an indicator of NO production. After collection of 100 ml of cell culture medium, 50 ml of 1% sulfanilamide was added to each well, and the plate was incubated at room temperature for 10 min. 0.1% naphtylethylenediamine containing 5% phosphoric acid was then added, and the plate was incubated at room temperature for 10 min. The absorbance of the content of each well was measured at a wavelength of 450 nm. The nitrite concentration was calculated from a nitrite standard curve generated by mixing 0 to 200 mM sodium nitrite solutions with the Griess reagent. The standard curve was typically linear between 0 and 200 mM of sodium nitrite.
Statistical Analysis The results are presented as the meanϮstandard error mean (S.E.M.). The data were analyzed by one-way ANOVA followed by Duncan's post-hoc test using SPSS. The differences were considered statistically significant at pϽ0.05.
RESULTS

Effect of Armeniacae semen Extract on Viability of BV2 Cells
In order to assess the cytotoxic effect of Armeniacae semen extract on the mouse microglial cells, BV2 cells were cultured with Armeniacae semen at final concentrations of 10 Ϫ3 mg/ml, 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 10 mg/ml for 24 h, and MTT assays was then carried out. Cells cultured in Armeniacae semen-free media was used as the control. The viability of cells incubated with Armeniacae semen extract at concentrations of 10 Ϫ3 mg/ml, 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 10 mg/ml for 24 h was 102.30Ϯ 1.57%, 97.05Ϯ0.61%, 98.12Ϯ4.03%, 94.50Ϯ2.48%, and 53.63Ϯ1.11% of the control value, respectively (Fig. 1) .
The present results show that Armeniacae semen extract exerted no significant cytotoxicity until it was at a concentration of 10 mg/ml.
Effect of Armeniacae semen Extract on mRNA Expression of COX-1, COX-2, and iNOS RT-PCR analysis of the mRNA level of COX-1, COX-2 and iNOS was performed in order to provide an estimate of the relative level of expression of these genes. In the present study, the mRNA level of COX-1, COX-2 and iNOS in the control cells was set as 1.00.
The level of COX-1 mRNA following treatment with 2 mg/ml LPS for 24 h was 0.96Ϯ0.05. The level of COX-1 mRNA when the cells were treated with Armeniacae semen extract at concentrations of 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 100 mM acetylsalicylic acid (ASA) was 0.88Ϯ0.02, 0.79Ϯ0.01, 0.82Ϯ0.04, and 0.33Ϯ0.04, respectively. The level of COX-2 mRNA was markedly increased to 10.07Ϯ1.26 following a treatment with 2 mg/ml LPS for 24 h. The level of COX-2 mRNA was decreased to 6.62Ϯ0.86, 3.49Ϯ0.44, 1.85Ϯ0.23, and 2.17Ϯ0.252 in cells treated Armeniacae semen extract at 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 100 mM ASA, respectively. The level of iNOS mRNA following a treatment with 2 mg/ml LPS for 24 h was markedly increased to 8.17Ϯ1.48. The level of iNOS mRNA was decreased to 6.14Ϯ1.00, 4.01Ϯ0.73, 3.03Ϯ0.91, and 3.48Ϯ0.70 in cells treated with Armeniacae semen extract at 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 100 mM ASA, respectively (Fig. 2) .
The present results show that LPS enhanced COX-2 and iNOS mRNA expression in BV2 cells and Armeniacae semen extract suppressed LPS-induced COX-2 and iNOS mRNA expression. However, LPS and Armeniacae semen extract slightly decreased COX-1 mRNA expression.
Western Blot Analysis of COX-1, COX-2, and iNOS Protein LPS treatment did not enhance the expression of COX-1 protein. Treatment with 10
Ϫ2 mg/ml, 10 Ϫ1 mg/ml, and 1 mg/ml of Armeniacae semen slightly decreased COX-1 (72 kDa) protein expression. Treatment with 2 mg/ml LPS for 24 h increased the level of COX-2 protein (74 kDa) and iNOS protein (130 kDa) in BV2 cells. Treatment with Armeniacae semen at 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 100 mM ASA, however, decreased the LPS-induced expression of COX-2 protein and iNOS protein (Fig. 3) .
The present results show that LPS enhanced COX-2 and iNOS protein expressions in BV2 cells and Armeniacae semen extract suppressed LPS-induced COX-2 protein and iNOS protein expression. However, LPS and Armeniacae semen extract slightly decreased COX-1 protein expression.
Effect of Armeniacae semen Extract on PGE 2 Snthesis From PGE 2 immunoassay, the amount of PGE 2 from the culture medium was increased from 49.23Ϯ1.03 pg/ml to 227.25Ϯ11.89 pg/ml after 24 h of exposure to LPS. PGE 2 synthesis was decreased to 114.92Ϯ5.67 pg/ml, 77.25Ϯ 8.90 pg/ml, 63.79Ϯ10.67 pg/ml, and 71.67Ϯ8.23 pg/ml by the treatment with Armeniacae semen extract at 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 100 mM ASA, respectively (Fig. 4) . The present results show that LPS enhanced PGE 2 synthesis in BV2 cells and Armeniacae semen extract suppressed LPS-induced PGE 2 synthesis.
Effect of Armeniacae semen Extract on NO Synthesis From the NO detection assay, the amount of nitrite was increased from 1.10Ϯ0.14 to 7.67Ϯ0.67 mM after 24 h of exposure to LPS. NO synthesis was decreased to 5.65Ϯ0.36 mM, 4.65Ϯ0.23 mM, 1.03Ϯ0.02 mM, and 2.58Ϯ0.34 mM by treatment with Armeniacae semen extract at 10 Ϫ2 mg/ml, 10 Ϫ1 mg/ml, 1 mg/ml, and 100 mM ASA, respectively (Fig. 5) .
The present results show that LPS enhanced NO synthesis in BV2 cells and Armeniacae semen extract suppressed LPSinduced NO synthesis. 
DISCUSSION
Microglia are the macrophage-like cells of the central nervous system (CNS), and they generally considered as immunologically quiescent under normal conditions. Exaggerated pain is induced by the activation of astrocytes and microglia. Astrocytes and microglia are activated by pain-inducing neurotransmitters including substance P, glutamate, and fractalkine. These neurotransmitters are known to excite the pain-responsive neurons, resulting in the production of reactive oxygen species (ROS), NO, prostaglandins (PGs), 452 Vol. 28, No. 3 and growth factors. 19) Microglia activation induced by CNS injury or infection is associated with neurodegenerative disorders and the release of proinflammatory cytokines. 20) These cytokines are the critical mediators of exaggerated pain.
In the present study, LPS treatment enhanced the expression of COX-2 and iNOS, and it increased the synthesis of PGE 2 and NO in mouse BV2 microglial cells. PGE 2 and NO are known to be involved in the processes of inflammation and carcinogenesis. Inducible COX-2 and iNOS are mainly responsible for the production of PGE 2 and NO. 21, 22) Immunosuppressive drugs such as cyclosporine, tacrolimus, methotrexate, and azathioprine are known to usually downregulate the functions of T-cell and they suppress cytokines production and release. As these pro-inflammatory cytokines are known to activate the transcription of COX-2 and iNOS genes, immunosuppressive drugs may also reduce PGs and NO production. 23, 24) In the present study, Armeniacae semen extract inhibited LPS-stimulated enhancement of COX-2 enzyme activity and PGE 2 production in the mouse BV2 microglial cells. Elevation of COX-2 activity is closely associated with the occurrence of cancers, arthritis, and several types of neurodegenerative disorders. PGE 2 , a major metabolite of the COX-2 pathway, has emerged as an important lipid mediator of inflammatory and immunoregulatory processes. PGE 2 has been implicated in the pathogenesis of acute and chronic inflammatory disease states. 25) Specific COX-2 inhibitors are also known to attenuate the symptoms of inflammation. 14, 26) In the present study, Armeniacae semen extract inhibited LPS-stimulated enhancement of iNOS enzyme activity and NO production in the mouse BV2 microglial cells. COX activity and the subsequent production of PGE 2 are closely related to the generation of the NO radical. It was reported that NO modulates the activity of COX-2 in a cGMP-independent manner, and NO plays a critical role in the release of PGE 2 by the direct activation of COX-2. 27) NO produced by the constitutive isoform of NOS is a key regulator of homeostasis and an important mediator of inflammation in several animal models. 28) Especially, the generation of NO by iNOS plays an important role in inflammation, host-defense responses, and tissue repair. 29) After exposure to endogenous and exogenous stimulators such as LPS and viral infections, iNOS is quantitatively induced in various cells, and it triggers several deleterious cellular responses inducing inflammation, sepsis, and stroke. 16, 30) Inhibition of the iNOS expression in murine macrophages has been suggested as another possible mechanism of non-steroidal anti-inflammatory drugs. 31) In the present study, Armeniacae semen extract suppressed PGE 2 and NO production by inhibiting LPS-stimulated enhancement of COX-2 enzyme activity and iNOS expression in the BV2 microglial cells. Armeniacae semen is known to have antidiarroheic, antipyretic, antiemetic, and anthelmintic effects. 1, 2) The anti-inflammatory and analgesic activities of Armeniacae semen have also been previously reported. 2, 32) Armeniacae semen has traditionally been used as an ingredient of some oriental medicine prescriptions for relieving of pain and inflammation. Xiao Qing Long Tang and Xing Su San are traditional medicines that have Armeniacae semen in their formulation, and these medicines are used for the treatment of bronchitis, asthma with fever, headache and pain in limbs. Armeniacae semen is also used in the Sang Ju Yin medication which is the prescription for the treatment of influenza, pneumonia, and acute tonsillitis.
Armeniacae semen possesses glycoside, amygdaline, starch, fatty acids and etc. Of these, amygdalin is known to be abundant in the Armeniacae semen. The content of amygdalin in the Armeniacae semen used in this study was 11.00%. Amygdalin has been used as anti-cancer drug, and it was also reported that amygdalin is effective for the relief of pain. [3] [4] [5] Based on the results, the suppressive effect of Armeniacae semen on COX-2 and iNOS presented in this study can be ascribed to the action of amygdalin. Our present study has shown that Armeniacae semen exerts anti-inflammatory and analgesic effects probably by suppressing COX-2 and iNOS expressions, and resulting in the inhibition of PGE 2 and NO synthesis.
